Dermapharm Holding SEDermapharm Holding SE - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Full ESG analysis of Dermapharm Holding SE can be accessed by signing in. Alternative companies in the scoring industry group for Dermapharm Holding SE are displayed. The dashboard includes a Q&A table for Dermapharm Holding SE.

Dermapharm Holding SE in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.2; made up of an environmental score of 6.7, social score of 6.9 and governance score of 8.0.

SDG Transparency Score for Dermapharm Holding SE 
Low
0 - 3
Medium
4 - 6

7.2

High Impact
7 - 10
Last Score Update: 2024-05-01
What drives the score for Dermapharm Holding SE 
6.7

Environmental

6.9

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
191Wockhardt Ltd
7.3
High
191Zealand Pharma A/S
7.3
High
217Dermapharm Holding SE
7.2
High
217Eurofins Scientific SE
7.2
High
217Genus PLC
7.2
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Dermapharm Holding SE have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Dermapharm Holding SE report the average age of the workforce?

LockedSign up for free to unlock

Does Dermapharm Holding SE reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose cybersecurity risks?

LockedSign up for free to unlock

Does Dermapharm Holding SE offer flexible work?

LockedSign up for free to unlock

Does Dermapharm Holding SE have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Dermapharm Holding SE conduct supply chain audits?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Dermapharm Holding SE conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose water use targets?

LockedSign up for free to unlock

Does Dermapharm Holding SE have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Dermapharm Holding SE have a product recall in the last two years?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose incidents of discrimination?

LockedSign up for free to unlock

Does Dermapharm Holding SE allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Dermapharm Holding SE issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose parental leave metrics?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Dermapharm Holding SE support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Dermapharm Holding SE reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Dermapharm Holding SE involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose its waste policy?

LockedSign up for free to unlock

Does Dermapharm Holding SE report according to TCFD requirements?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose energy use targets?

LockedSign up for free to unlock

Does Dermapharm Holding SE disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Dermapharm Holding SE have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Dermapharm Holding SE
These potential risks are based on the size, segment and geographies of the company.

Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.

Sorry!

Failed to process!